tiprankstipranks
Suven Pharmaceuticals Ltd. (IN:COHANCE)
:COHANCE
India Market
COHANCE
Suven Pharmaceuticals Ltd.
RESEARCH TOOLSreports
Want to see IN:COHANCE full AI Analyst Report?

Suven Pharmaceuticals Ltd. (COHANCE) Financial Statements

2 Followers

Suven Pharmaceuticals Ltd. Financial Overview

Suven Pharmaceuticals Ltd.'s market cap is currently ₹160.87B. The company's EPS TTM is ₹9.7; its P/E ratio is 64.28; Suven Pharmaceuticals Ltd. is scheduled to report earnings on May 12, 2026, and the estimated EPS forecast is ₹0.82. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 22.69B₹ 11.98B₹ 10.51B₹ 13.40B₹ 13.20B
Gross Profit₹ 9.11B₹ 8.22B₹ 6.80B₹ 7.52B₹ 7.46B
Operating Income₹ 2.40B₹ 5.66B₹ 5.40B₹ 6.30B₹ 6.33B
EBITDA₹ 4.27B₹ 4.06B₹ 4.09B₹ 5.73B₹ 5.79B
Net Income₹ 1.79B₹ 2.68B₹ 3.00B₹ 4.11B₹ 4.54B
Balance Sheet
Cash & Short-Term Investments₹ 3.26B₹ 2.90B₹ 8.21B₹ 4.84B₹ 5.26B
Total Assets₹ 57.30B₹ 30.32B₹ 22.54B₹ 19.66B₹ 18.30B
Total Debt₹ 4.00B₹ 2.79B₹ 649.96M₹ 703.41M₹ 971.27M
Net Debt₹ 3.41B₹ 1.94B₹ 177.65M₹ 55.38M₹ 525.63M
Total Liabilities₹ 16.96B₹ 11.91B₹ 2.03B₹ 2.31B₹ 3.02B
Stockholders' Equity₹ 39.11B₹ 16.97B₹ 20.51B₹ 17.35B₹ 15.27B
Cash Flow
Free Cash Flow₹ 1.35B₹ 1.32B₹ 3.07B₹ 1.65B₹ 2.55B
Operating Cash Flow₹ 3.55B₹ 2.88B₹ 3.58B₹ 4.51B₹ 3.30B
Investing Cash Flow₹ -2.58B₹ -2.55B₹ -3.62B₹ -1.95B₹ -1.36B
Financing Cash Flow₹ -1.49B₹ 33.20M₹ -138.02M₹ -2.36B₹ -1.56B
Currency in INR

Suven Pharmaceuticals Ltd. Earnings and Revenue History

Income Statement >

Suven Pharmaceuticals Ltd. Debt to Assets

Balance Sheet >

Suven Pharmaceuticals Ltd. Cash Flow

Cash Flow >

Suven Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

Earnings >